Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial

BACKGROUND: Patients with advanced sarcomas have a poor prognosis and few treatment options that improve overall survival. We assessed the efficacy and tolerability of pemetrexed and cisplatin combination therapy in patients with refractory bone and soft tissue sarcoma (STS). PATIENTS AND METHODS: P...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, J.H., Kim, S.H., Jeon, M.K., Kim, J.E., Kim, K.H., Yun, K.-H., Jeung, H.-C., Rha, S.Y., Ahn, J.-H., Kim, H.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424216/
https://www.ncbi.nlm.nih.gov/pubmed/34482181
http://dx.doi.org/10.1016/j.esmoop.2021.100249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424216/
https://www.ncbi.nlm.nih.gov/pubmed/34482181
http://dx.doi.org/10.1016/j.esmoop.2021.100249

Ejemplares similares